Technical Analysis for BIB - ProShares Ultra Nasdaq Biotechnology

Grade Last Price % Change Price Change
grade D 47.82 -2.86% -1.41
BIB closed down 2.86 percent on Friday, July 19, 2019, on 86 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
3 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical BIB trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
MACD Bearish Centerline Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Support Bullish -2.86%
Stochastic Buy Signal Bullish -2.86%
Oversold Stochastic Weakness -2.86%
Crossed Above 50 DMA Bullish -1.30%
Oversold Stochastic Weakness -1.30%

Older signals for BIB ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.
Exchange Traded Funds Stock Market Index Biotechnology Nasdaq Economy Of New York City Nasdaq 100 Nasdaq Biotechnology Total Return Index
Is BIB a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 11 Big Biopharma in the red as investors wait for Trump's drug price plan
Jul 9 Drug makers perk up on block of price disclosures in TV ads
Jul 8 Biotechs and biopharmas under pressure ahead of Trump order on drug prices
Jul 2 U.S. drugmakers institute new round of increases
Jun 25 BIB Versus LABU: Comparing Leveraged Biotech ETFs
May 13 FDA finalizes guidance on interchangeable biosimilars
May 8 Drug makers to face added pricing pressure in Canada under new proposal - Reuters
May 8 Drug makers to disclose prices in TV ads as early as this summer
May 7 Biotech ETFs in Focus on String of Q1 Earnings Beats
Apr 24 Will Biotech ETFs Continue to Rally in Q1 Earnings?
See more BIB news...
Indicators
Indicator Value
52 Week High 70.82
52 Week Low 36.05
Average Volume 140,743
200-Day Moving Average 51.7179
50-Day Moving Average 48.3982
20-Day Moving Average 50.3535
10-Day Moving Average 49.41
Average True Range 1.5742
ADX 13.92
+DI 19.2086
-DI 23.7526
Chandelier Exit (Long, 3 ATRs ) 48.7774
Chandelier Exit (Short, 3 ATRs ) 52.4326
Upper Bollinger Band 53.5987
Lower Bollinger Band 47.1083
Percent B (%b) 0.11
BandWidth 12.88967
MACD Line -0.1388
MACD Signal Line 0.3028
MACD Histogram -0.4416
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 50.45
Resistance 3 (R3) 50.70 50.08 50.01
Resistance 2 (R2) 50.08 49.41 49.95 49.86
Resistance 1 (R1) 48.95 49.00 48.64 48.70 49.72
Pivot Point 48.33 48.33 48.18 48.20 48.33
Support 1 (S1) 47.20 47.66 46.89 46.95 45.92
Support 2 (S2) 46.58 47.25 46.45 45.78
Support 3 (S3) 45.45 46.58 45.63
Support 4 (S4) 45.20